CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNY

Measles, combinations with mumps and rubella, live attenuated

Phase 3
Sanofi (SNY)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '26
SNYPhase 3

Measles, combinations with mumps and rubella, live attenuated Phase 3 Est. Readout

Measles, combinations with mumps and rubella, live attenuated
Nov 2026~
CT.gov
00%
Competitive Landscape

2 competitors in Yellow Fever Immunization

View Full Landscape
Drug Information

Target Indication

Yellow Fever Immunization

Clinical Trial

NCT07103148

Last updated: 12/8/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.